Wave life sciences to present at 2024 rbc capital markets global healthcare conference

Cambridge, mass., may 07, 2024 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage biotechnology company focused on unlocking the broad potential of rna medicines to transform human health, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the 2024 rbc capital markets global healthcare conference in new york city on tuesday, may 14, 2024, at 8:30 a.m. et.
WVE Ratings Summary
WVE Quant Ranking